Literature DB >> 16869736

Polygenic inherited predisposition to breast cancer.

B A J Ponder1, A Antoniou, A Dunning, D F Easton, P D P Pharoah.   

Abstract

The known breast cancer predisposing genes account for only about 20% of inherited susceptibility. Epidemiological analyses suggest that much of the remaining 80% is explained by the combined effect of many individually weak genetic variants, rather than by further rare, highly penetrant mutations. In the near term, identification of variants may indicate new pathways or mechanisms in breast cancer development. The polygenic model implies a wide distribution of risk in the population. In the longer term, it may be possible to construct individual risk profiles to guide public health interventions. The search for genetic variants has so far proved difficult. A key unanswered question is the "genetic architecture" of predisposition-that is, strong or weak alleles, common or rare. We describe a genome-wide scan designed to provide a first-pass answer to this question.

Entities:  

Mesh:

Year:  2005        PMID: 16869736     DOI: 10.1101/sqb.2005.70.029

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  12 in total

Review 1.  Genetic susceptibility loci for breast cancer by estrogen receptor status.

Authors:  Montserrat Garcia-Closas; Stephen Chanock
Journal:  Clin Cancer Res       Date:  2008-12-15       Impact factor: 12.531

2.  Risk of contralateral breast cancer associated with common variants in BRCA1 and BRCA2: potential modifying effect of BRCA1/BRCA2 mutation carrier status.

Authors:  Jane C Figueiredo; Jennifer D Brooks; David V Conti; Jenny N Poynter; Sharon N Teraoka; Kathleen E Malone; Leslie Bernstein; Won D Lee; David J Duggan; Ashley Siniard; Patrick Concannon; Marinela Capanu; Charles F Lynch; Jørgen H Olsen; Robert W Haile; Jonine L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2010-12-15       Impact factor: 4.872

3.  BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing.

Authors:  Kumaravel Somasundaram
Journal:  Indian J Surg Oncol       Date:  2011-03-11

4.  A novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and function.

Authors:  Arcangela De Nicolo; Mariella Tancredi; Grazia Lombardi; Cristina Chantal Flemma; Serena Barbuti; Claudio Di Cristofano; Bijan Sobhian; Generoso Bevilacqua; Ronny Drapkin; Maria Adelaide Caligo
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

5.  Variation of breast cancer risk among BRCA1/2 carriers.

Authors:  Colin B Begg; Robert W Haile; Ake Borg; Kathleen E Malone; Patrick Concannon; Duncan C Thomas; Bryan Langholz; Leslie Bernstein; Jørgen H Olsen; Charles F Lynch; Hoda Anton-Culver; Marinela Capanu; Xiaolin Liang; Amanda J Hummer; Cami Sima; Jonine L Bernstein
Journal:  JAMA       Date:  2008-01-09       Impact factor: 56.272

6.  The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes.

Authors:  Julie K Johnson; Nic Waddell; Georgia Chenevix-Trench
Journal:  BMC Cancer       Date:  2012-06-15       Impact factor: 4.430

7.  Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families.

Authors:  Adalgeir Arason; Haukur Gunnarsson; Gudrun Johannesdottir; Kristjan Jonasson; Pär-Ola Bendahl; Elizabeth M Gillanders; Bjarni A Agnarsson; Göran Jönsson; Katri Pylkäs; Aki Mustonen; Tuomas Heikkinen; Kristiina Aittomäki; Carl Blomqvist; Beatrice Melin; Oskar T H Johannsson; Pål Møller; Robert Winqvist; Heli Nevanlinna; Ake Borg; Rosa B Barkardottir
Journal:  Breast Cancer Res       Date:  2010-07-16       Impact factor: 6.466

8.  Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women.

Authors:  Lap Ah Tse; Mengjie Li; Wing-cheong Chan; Chi-hei Kwok; Siu-lan Leung; Cherry Wu; Ignatius Tak-sun Yu; Wai-cho Yu; Xiangqian Lao; Xiaorong Wang; Carmen Ka-man Wong; Priscilla Ming-yi Lee; Feng Wang; Xiaohong Rose Yang
Journal:  PLoS One       Date:  2015-03-10       Impact factor: 3.240

9.  Loss of the BRCA1-interacting helicase BRIP1 results in abnormal mammary acinar morphogenesis.

Authors:  Kazuhiro Daino; Tatsuhiko Imaoka; Takamitsu Morioka; Shusuke Tani; Daisuke Iizuka; Mayumi Nishimura; Yoshiya Shimada
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

10.  Validation of six genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat and assessment of their relevance to breast cancer risk in humans.

Authors:  John A Colletti; Kristin M Leland-Wavrin; Scott G Kurz; Maureen Peters Hickman; Nicole L Seiler; Nyssa Becker Samanas; Quincy A Eckert; Kirsten L Dennison; Lina Ding; Beverly S Schaffer; James D Shull
Journal:  G3 (Bethesda)       Date:  2014-05-28       Impact factor: 3.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.